¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"mumps meningoencephalitis"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® epidemic parotitis, mumps ÇÑ±Û º¼°Å¸®, À¯Çà±Í¹Ø»ù¿°
¼³¸í   
  ÁַΠ¼Ò¾Æ¿¡¼­ ÀϾ°í, ±× °á°ú·Î Áö¼Ó¼º ¸é¿ªÀ» Áִ Àü¿°¼ºÀÇ paramyxovirus º´. Èí±â¿¡ ÀÇÇØ¼­ °¨¿°µÇ´Âµ¥, °¡Àå ³óÈÄÇÑ ¹ÙÀÌ·¯½º°¨¿°Àº Ä§»ù³»¿¡ »ý±â¸ç, Æ¯È÷ ÅιػùÀ̳ª Çô¹Ø»ùº¸´Ùµµ ±Í¹Ø»ùÀÌ ´õ¿í ½ÉÇÏ´Ù. Àẹ±â´Â 18~22ÀÏÀÌ´Ù. °¨¿°Àº ¾à 75%ÀÇ Áõ·Ê¿¡¼­ Áõ»óÀ» ³ªÅ¸³½´Ù. À̵é Áß ±Í¹Ø»ù¿°Àº 70%¿¡¼­, ¼ö¸·¿°Àº 10~15%(À̵é Áß ¹Ý¼ö¿¡¼­ ¹«Áõ»ó¼º ¼ö¾×¼¼Æ÷ Áõ°¡ÁõÀÌ µ¿¹ÝµÈ´Ù)¿¡¼­ ÀϾ´Ù. ºÎ°íȯ°íȯ¿°ÀÌ »çÃá±â ÈÄÀÇ ³²¼º¿¡¼­ »ý±âÁö¸¸ ±× ÈÄ¿¡ ºÒÀÓÁõÀ» ¼Ó¹ßÇϴ ÀÏÀº µå¹°´Ù. ±× ¿ÜÀÇ Áõ»óÀº º¸´Ù µå¹°°Ô ³ªÅ¸³ª´Âµ¥ ÀÌÀÚ¿°, °üÀý¿°, ½É±Ù¿°, ³­¼Ò¿°, °©»ó»ù¿° ¹× Á¥»ù¿° µîÀÌ ÀÖ´Ù. ¹ß¿­°ú È¯ºÎÀÇ À¯Å뼺 ¿°ÁõÀº ÃÖÃÊÀÇ 2Àϰ£¿¡ °¡Àå ÇöÀúÇ졒ʫÙÀ½ 4~5ÀÏÀÌ Áö³ª¸é ¼­¼­È÷ °¡¶ó¾É´Â´Ù. µ¿½Ã¿¡ ÇÑ ºÎÀ§ ÀÌ»óÀ» Ä§½ÀÇϴ ¼öµµ ÀÖÀ¸¸ç °¡²û ¼Ó¹ßÀûÀ¸·Î Ä§½ÀµÇ°í ÁúȯÀÇ Àü °æ°ú´Â 2~3ÁÖ¿¡ À̸¥´Ù. ºÎ¼öµÇ´Â ¿µ¼Ó¼ºÀÇ ½Å°æÇÐÀû ¼Õ»óÀ» µ¿¹ÝÇϴ ¼ö¸·³ú¿°Àº µå¹°´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • mumps
    º¼°Å¸®, À¯Çà±Í¹Ø»ù¿°, À¯Ç༺ÀÌÇϼ±¿°
  • mumps orchitis
    º¼°Å¸®°íȯ¿°
  • amebic meningoencephalitis
    ¾Æ¸Þ¹Ù¼ö¸·³ú¿°
  • acanthamoeba meningoencephalitis
    °¡½Ã¾Æ¸Þ¹Ù¼ö¸·³ú¿°
  • eosinophilic meningoencephalitis
    È£»ê±¸¼ö¸·³ú¿°
  • meningoencephalitis
    ¼ö¸·³ú¿°
  • primary amebic meningoencephalitis
    ¿ø¹ß¾Æ¸Þ¹Ù¼ö¸·³ú¿°
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • mumps
    º¼°Å¸®, À¯Çà±Í¹Ø»ù¿°
  • meningoencephalitis
    ¼ö¸·³ú¿°
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • mumps
    º¼°Å¸®, À¯Çà±Í¹Ø»ù¿°
  • mumps orchitis
    º¼°Å¸®°íȯ¿°
  • acanthamoeba meningoencephalitis
    °¡½Ã¾Æ¸Þ¹Ù¼ö¸·³ú¿°
  • amebic meningoencephalitis
    (¢¡primary amebic meningoencephalitis) ¿ø¹ß¾Æ¸Þ¹Ù¼ö¸·³ú¿°
  • eosinophilic meningoencephalitis
    È£»ê±¸¼ö¸·³ú¿°
  • meningoencephalitis
    ¼ö¸·³ú¿°
  • primary amebic meningoencephalitis
    ¿ø¹ß¾Æ¸Þ¹Ù¼ö¸·³ú¿°
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • amebic meningoencephalitis
    ¾Æ¸Þ¹Ù¼º ¼ö¸·³ú¿°
  • herpes meningoencephalitis ³ª
    Ç츣Æä½º¼ö¸·³ú¿°.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • amebic meningoencephalitis
    ¾Æ¸Þ¹Ù¼º ¼ö¸·³ú¿°
  • chronic meningoencephalitis
    ¸¸¼º¼ö¸·³ú¿°(¡­âÐØ¯Òàæú).
  • eosinophilic meningoencephalitis
    È£»ê±¸¼º ³ú¸·¿°
  • herpes meningoencephalitis ³ª
    Ç츣Æä½º¼ö¸·³ú¿°.
  • meningoencephalitis
    ¼ö¸·³ú¿°(¡­Òàæú).
  • meningoencephalitis
    ¼ö¸·³ú¿°(¡­Òàæú)
  • meningoencephalitis
    ¼ö¸·³ú¿°
  • syphilitic meningoencephalitis
    ¸Åµ¶¼º ³ú¸·³ú¿°(¡­ÒàØ¯Òàæú).[Á¤½Å]¸Åµ¶ ¼º ³ú¼ö¸·¿°, ¸Åµ¶¼º ³ú¸·¿°.
  • epidemic parotitis =mumps
    À¯Ç༺ ÀÌÇϼ±¿°
  • epidemic parotitis =mumps
    À¯Ç༺ ÀÌÇϼ±¿°.
  • metastatic mumps
    ÀüÀ̼º ¸ØÇÁ½º.
  • metastatic mumps
    ÀüÀ̼º ¸ØÇÁ½º.
  • mumps
    º¼°Å¸®, ¸ØÇÁ½º, À¯Ç༺ ÀÌÇϼ±¿°(êüú¼àõì¼ù»àÍæú).
  • mumps
    À¯Ç༺ ÀÌÇϼ±¿°(×µú¼àõ ì¼ù»àÍæú)
  • mumps
    º¼°Å¸®
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • acanthamoeba meningoencephalitis
    °¡½Ã¾Æ¸Þ¹Ù¼ö¸·³ú¿°
  • amebic meningoencephalitis
    ¾Æ¸Þ¹Ù¼ö¸·³ú¿°
  • eosinophilic meningoencephalitis
    È£»ê±¸¼ö¸·³ú¿°
  • primary amebic meningoencephalitis
    ¿ø¹ß¼º¾Æ¸Þ¹Ù¼ö¸·³ú¿°
  • secondary amebic meningoencephalitis
    ÀÌÂ÷¾Æ¸Þ¹Ù¼ö¸·³ú¿°
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • meningoencephalitis
    ¼ö¸·³ú¿°
  • mumps
    º¼°Å¸®, ¸ØÇÁ½º, À¯Ç༺ÀÌÇϼ±¿°
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
MMR   1) Measles, Mumps, Rubella; È«¿ª, ¸ØÇÁ½º, dzÁø
  2) Mass Miniature Radiography...
MMR mass miniature radiography; masseter muscle rigidity; maternal mortality rate; measles-mumps-rubella...
MUMPS Massachusetts General Hospital Utility Multi-Programming System
AME amphotericin methyl ester; apparent minerallocorticoid excess; aseptic meningoencephalitis
BME basal medium Eagle; biundulant meningoencephalitis; brief maximal effort
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
PAM Primary Amebic Meningoencephalitis
MMR MEASLES: mumps-rubella
MMR Measles, mumps and rubella
MMR Measles-Mumps-Rubella vaccine
MuV Mumps virus
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • chemical mumps
    È­Çмº À¯Ç༺ ÀÌÇϼ±¿°
  • mumps orchitis
    ÀÌÇϼ±¿°¼º °íȯ¿°
  • chronic meningoencephalitis
    ¸¸¼º ¼ö¸· ³ú¿°
  • eosinophilic meningoencephalitis
    È£»ê±¸¼º ³ú¸·¿°
  • meningoencephalitis
    ¼ö¸· ³ú¿°
    ³ú¿Í ¼ö¸·ÀÇ ¿°Áõ.
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
mumps meningoencephalitis A usually benign nervous system infection arising during the active phase of clinical mumps parotiditis.
(05 Mar 2000)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
acute primary haemorrhagic meningoencephalitis A disease characterised by acute onset of fever, followed by convulsions, delirium, and coma, and associated with perivascular demyelination and haemorrhagic foci in the central nervous system.
Synonym: acute primary haemorrhagic meningoencephalitis, Strumpell's disease.
(05 Mar 2000)
biundulant meningoencephalitis tick-borne encephalitis (Central European subtype)
meningoencephalitis Inflammation of both the brain and meninges.
(12 Dec 1998)
chronic progressive syphilitic meningoencephalitis Syphilitic infection manifested as dementia (often with delusional features), dysarthria, seizures, myoclonic jerks, action tremor, impaired walking and standing, pupillary abnormalities, and abnormal CSF findings.
Synonym: chronic progressive syphilitic meningoencephalitis.
(05 Mar 2000)
primary amoebic meningoencephalitis An invasive, rapidly fatal cerebral infection by soil amoebae, chiefly Naegleria fowleri, found in man and other primates and experimentally in rodents; the disease is characterised by a high fever, neck rigidity, and symptoms associated with upper respiratory infection such as cough and nausea; although organisms have been cultured from various organs, the brain is the primary focus, especially the olfactory lobes and cerebral cortex, which are first attacked by the amoebae that enter from nasal mucosa through the cribriform plate; death usually occurs two to three days after onset of symptoms.
(05 Mar 2000)
herpetic meningoencephalitis A severe form of meningoencephalitis caused by herpesvirus type 1 and associated with a high mortality rate; definite diagnosis depends upon isolation of the virus or demonstration of viral antigens.
(05 Mar 2000)
syphilitic meningoencephalitis A secondary or tertiary stage manifestation of syphilis; rarely fatal.
(05 Mar 2000)
thromboembolic meningoencephalitis An acute septicaemic disease of cattle caused by the bacterium Haemophilus somnus and characterised by fever, severe depression, ataxia, blindness, coma, and rapid death.
(05 Mar 2000)
eosinophilic meningoencephalitis A disease caused by infection with the rat lungworm, Angiostrongylus cantonensis, whose larvae, ingested with infected slugs or land snails (or some unidentified transport host), migrate from intestine to the meninges of the brain where the disease is produced; it is usually mild, of short duration, and characterised by fever, eosinophilia, and white blood cells (rarely nematode larvae) in the spinal fluid.
(05 Mar 2000)
turkey meningoencephalitis virus A virus of the genus Flavivirus causing paralysis and enteritis in turkeys in Israel.
(05 Mar 2000)
vaccination, mumps See Vaccination, MMR. Vaccination, pneumococcal pneumonia: this vaccine, which prevents one of the most common and severe forms of pneumonia, is usually given only once in a lifetime, usually after the age of 55, to someone with ongoing lung problems (such as chronic obstructive pulmonary disease (copd) or asthma) or other chronic diseases (including those involving the heart and kidneys). This vaccination would rarely be given to children.
(12 Dec 1998)
measles, mumps and rubella vaccine A combination of live attenuated measles, mumps, and rubella viruses in an aqueous suspension; used for immunization against the respective diseases.
(05 Mar 2000)
metastatic mumps Mumps complicated by involvement of organs other than parotid glands, such as the testis, breast, or pancreas.
(05 Mar 2000)
mumps An infectious acute viral disease affecting the parotid glands. The gonads, meninges and pancreas can also be affected. The causative agent is a paramyxovirus. Humans are the only natural host for this disease.
Common symptoms include weakness, fever, sore throat, malaise and puffiness to the cheeks (due to parotid gland swelling). Patients are contagious 1 day prior to the onset of swelling until the swelling is gone. Recovery is generally in 2 weeks.
(27 Sep 1997)
mumps immunization The standard MMR vaccine is given to prevent measles, mumps and rubella (german measles). The mmr vaccine is now given in two dosages. The first should be given at12-15 months of age. The second vaccination should be given at 4-6 years (or, alternatively, 11-12 years) of age. most colleges require proof of a second measles or mmr vaccination prior to entrance. Most children should receive mmr vaccinations. Exceptions may include children born with an inability to fight off infection, some children with cancer, on treatment with radiation or drugs for cancer, on long term steroids (cortisone). People with severe allergic reactions to eggs or the drug neomycin should probably avoid the mmr vaccine. Pregnant women should wait until after delivery before being immunised with mmr. People with HIV or aids should normally receive mmr vaccine. Measles, mumps, and rubella vaccines may be administered as individual shots, if necessary, or as a measles-rubella combination.
(12 Dec 1998)
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
mumps meningoencephalitis a usually benign form seen in children, caused by the mumps virus, and characterized by fever, vomiting, nuchal rigidity, lethargy, parotitis, headache, convulsions, abdominal pain, diarrhea, and delirium.
Ãâó: www.mercksource.com/pp/us/cns/cns_hl_dorlands.jspz...
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • mumps
    ÀÌÇϼ±¿°;Ç׾Ƹ® ¼Õ´Ô
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á